Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFB002 vs laser in diabetic macular edema (China)
CTR20131205Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2014
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in diabetic macular edema (DME), sponsored by Novartis. Started Oct 2014; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20131205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131205.